Atrial fibrillation (AF) is a complex condition requiring holistic management with multiple
treatment decisions about optimal thromboprophylaxis, symptom control (and prevention of …

Atrial disease or myopathy forms the substrate for atrial fibrillation (AF) and underlies the
potential for atrial thrombus formation and subsequent stroke. Current diagnostic …

Komisję ESC ds. Wytycznych Postępowania nadzoruje i koordynuje przygotowywanie
nowych wytycznych i stanowisk przez grupy robocze i inne grupy ekspertów. Komitet jest …

Background The benefit of oral anticoagulation in atrial fibrillation is based on a balance
between reduction in ischaemic stroke and increase in major bleeding. We aimed to …

Aims Atrial fibrillation (AF) is associated with an increased risk of stroke, which is currently
estimated by clinical characteristics. The cardiac biomarkers N-terminal fragment B-type …

Atrial fibrillation (AF) confers a substantial risk of mortality and morbidity from stroke and
thrombo-embolism, and this common cardiac arrhythmia represents a major healthcare …

Surveys and registries are needed to verify that real-life daily practice is in keeping with what
is recommended in the guidelines, thus completing the loop between clinical research …

Objective Atrial fibrillation is often asymptomatic, but outcomes require further
characterization. The study objective was to investigate the clinical presentation …

Background: Important improvements have been made in treatment of diseases associated
with atrial fibrillation (AF), such as hypertension, myocardial infarction, and heart failure …

Importance In approximately 20% of atrial fibrillation (AF)–related ischemic strokes, stroke is
the first clinical manifestation of AF. Strategies are needed to identify and therapeutically …